AR and adenocarcinoma: <i>Ascl1</i> loss in established NEPC results in transient tumor regression followed by recurrence; however, <i>Ascl1</i> deletion prior to transplantation completely abrogates lineage plasticity, yielding adenocarcinomas with elevated AR expression and marked sensitivity to castration.